Realizing the commercial potential of new cancer therapies requires the insight of clinicians who can help shape, enroll, and publish clinical studies that not only meet regulatory milestones but also capture endpoints that are meaningful to oncologists. Clinical advisors to Syndax have extensive academic credentials in translational and clinical research at major academic institutions.
Kapil N. Bhalla, MD
Director, MCG Cancer Research Center, Professor, Medical College of Georgia
Director, MCG Cancer Research Center, Professor, Medical College of Georgia
Dennis A. Carson, MD
Director, Rebecca and John Moores UCSD Cancer Center, Professor, University of California at San Diego
Director, Rebecca and John Moores UCSD Cancer Center, Professor, University of California at San Diego
George Q. Daley, MD, PhD
Associate Professor, Children’s Hospital, Boston; Harvard Medical School, Cambridge, MA
Associate Professor, Children’s Hospital, Boston; Harvard Medical School, Cambridge, MA
S. Gail Eckhardt, MD
Director, Developmental Therapeutics Program, Associate Professor, University of Colorado
Director, Developmental Therapeutics Program, Associate Professor, University of Colorado
Steven D. Gore, MD
Associate Professor, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Associate Professor, Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Jean Pierre Issa, MD
Professor, MD Anderson Cancer Center, University of Texas
Professor, MD Anderson Cancer Center, University of Texas
Edward A. Sausville, MD, PhD
Associate Director, Marlene and Stewart Greenebaum Cancer Center, Professor, University of Maryland
Associate Director, Marlene and Stewart Greenebaum Cancer Center, Professor, University of Maryland
George W. Sledge, Jr. MD
Professor, Indiana University Cancer Center
Professor, Indiana University Cancer Center
Neil L. Spector, MD
Duke University
Duke University
